Los Angeles, CA (SBWIRE) 02/09/2019 The research study is a highly useful tool in the hands of market players that allows them to effectively assess the global Generic Drugs market and know where they stand in the industry in terms of revenue or sales growth. It comprehensively evaluates the global Generic Drugs market with different perspectives for the purpose of providing a detailed, informative, and accurate analysis of regional growth, competition, market segmentation, and other important aspects. Furthermore, it offers a precise account of key breakthroughs and developments taking shape in the global Generic Drugs market. It takes into consideration both the global and regional progress of the Generic Drugs market to provide a complete analysis.
The global Generic Drugs market is valued at 210800 million US$ in 2018 is expected to reach 451800 million US$ by the end of 2025, growing at a CAGR of 10.0% during 2019-2025.
A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.
The global average gross margin of generic drugs is in the decreasing trend, from 45.19% in 2011 to 43.56% in 2015. With the situation of global economy, gross margin will be in decreasing trend in the following five years.
The classification of generic drugs includes simple generic drugs, super generic drugs and biosimilars. And the proportion of simple generic drugs in 2015 is about 80% and the proportion is in decreasing trend from 2011 to 2015. The super generic drugs in 2015 are about 18.7% and the proportion is in increasing trend from 2011 to 2015.
North America region is the largest supplier of generic drugs, with a revenue market share nearly 31.5% in 2015. Europe is the second largest supplier of generic drugs, enjoying revenue market share nearly 26.5% in 2015, India is also an important areas, and with the revenue market share is 22.8% in 2015.
Get PDF report template:https://www.qyresearch.com/sample-form/form/957962/global-generic-drugs-professional-analysis
This report focuses on Generic Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Generic Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Novartis - Sandoz
ENDO (Par Pharmaceutical)
Segment by Regions
Segment by Type
Simple Generic Drugs
Super Generic Drugs
Segment by Application
How will the report be a powerful addition to your resources?
The all-inclusive analysis of the global Generic Drugs market provided in the research study can accelerate the decision-making process of players as it offers a clear explanation of market growth threats, opportunities, development status, and trends. Players can ensure positive results for their quarterly and yearly earnings with the help of the complete evaluation of the global Generic Drugs market provided in the report. Growth statistics and useful recommendations such as business expansion plans in developing regions included in the research study will enable players to expect more growth in the global Generic Drugs market.
Players can build effective long-term as well as short-term business strategies using the report. The analysts highlight industry trends, key marketing strategies used by leading companies, and business profile of top players operating in the global Generic Drugs market.
Access Full Comprehensive Industry Insights:
The report is compiled with the use of advanced tools and latest primary and secondary research methodologies. Our experienced panel of analysts gathers information and data from annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases. In order to ensure the reliability of the information and data included in the report, our researchers conduct paid primary interviews with industry experts and other important entities associated with the global Generic Drugs market.
Highlights from the TOC:
Market Overview: Readers are provided with a brilliant overview of the global Generic Drugs market and the scope of products available for commercial sale. Here, the authors of the report also touch on key segments of the global Generic Drugs market and give a glimpse of the market size by value and volume.
Competition by Manufacturers: This section of the report shows how different manufacturers are performing in the global Generic Drugs market on the basis of average price, revenue, and production.
Production Market Share by Region: It includes market analysis of each region and country studied in the report in terms of gross margin, price, revenue, production, and growth rate.
Company Profiles and Key Figures in Business: It lists all players studied in the report on the basis of markets served, gross margin, price, revenue, production, product specification, application, and production sites.
Manufacturing Cost Analysis: It covers industrial chain analysis, raw material analysis, manufacturing cost structure, and other key aspects.
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.
For more information on this press release visit: http://www.sbwire.com/press-releases/generic-drugs-market-is-anticipated-to-grow-at-a-high-cagr-100-during-2019-2025-qy-research-1143227.htm
Media Relations Contact
Director - Digital Marketing
QY Research, Inc.
Email: Click to Email Rahul Singh